Ryu Kanzaki

16PUBLICATIONS
19CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Solid tumoursPredictive and prognostic markersSensor technology (incl. chemical aspects)Anaesthesiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jul 06, 2026
ASO Author Reflections: Reconsidering Surgical Indications for Clinical T4 Non-Small Cell Lung Cancer in the TNM 9th Edition Era.

|Jun 15, 2026
Treatment strategies and outcomes in patients with synchronous multiple primary malignancies involving lung cancer.

|Apr 21, 2026
CD81 promotes proliferation and predicts survival in lung squamous cell carcinoma.

|Sep 23, 2024
Retraction Note: CCM3 is a gatekeeper in focal adhesions regulating mechanotransduction and YAP/TAZ signalling.

Shan Wang, Emelie Englund, Pontus Kjellman

|Sep 08, 2024
FHL2 expression by cancer-associated fibroblasts promotes metastasis and angiogenesis in lung adenocarcinoma.

Ryu Kanzaki, Steven Reid, Paulina Bolivar

|Apr 22, 2024
Pathological Pleural Invasion is a Risk Factor for Late Recurrence in Long-Term Survivors of Non-small Cell Lung Cancer after Complete Resection.

Ryu Kanzaki, Hiroyuki Fukuda, Masao Kobayashi

Pageof 3

Frequent Collaborators

2 joint publications

Shan Wang

2 joint publications

Emelie Englund

2 joint publications

Zhen Li

2 joint publications

Johannes Kumra Ahnlide